Shining a Spotlight on AI Research at the Barts Cancer Institute
16th December 2024
We explore Nobel-Prize-winning research and the theory behind AI, and speak with Dr Vivek Singh, Dr Oscar Maiques and Professor Claude Chelala, three researchers using cutting-edge AI in their work at the BCI.
Read more
How non-cancerous cells in pancreatic cancer may weaken the immune system’s response
12th December 2024
New research sheds light on how certain non-cancerous cells in pancreatic cancer can affect the body’s natural immune defences and could have a significant impact on patients’ survival.
Read more
Professor Sarah McClelland awarded £1.5m from CRUK to study cancer’s chromosomal chaos
25th November 2024
Congratulations to Professor Sarah McClelland, who has received a £1,500,000 Programme Foundation Award from Cancer Research UK (CRUK), to support her lab’s work at Barts Cancer Institute (BCI), Queen Mary University of London.
Read more
Cancer-killing virus treatment shows promise in brain tumour trial
8th November 2024
An innovative cancer-killing virus shows promise for tackling glioblastoma, an aggressive type of brain tumour, according to new results from a phase I clinical trial co-led by researchers at Barts Cancer Institute.
Read more
€9.8m ERC Synergy grant awarded to study how human tissues stay healthy as we age
5th November 2024
Researchers at the BCI and the Crick have been awarded a €9.8m ERC Synergy grant for their pioneering 6-year project called MUTAHOME.
Read more
BCI paves the way for the next era of radiation research in £18m partnership
30th October 2024
The BCI is advancing radiation research through the Cancer Reserach UK City of London Radiation Research Centre of Excellence, an £18M partnership with the Crick, UCL and King’s.
Read more